- Home
- WINT
as 06-06-2025 4:00pm EST
Windtree Therapeutics Inc is a biotechnology company focused on advancing early and late-stage therapies for critical conditions and diseases. Its portfolio of product candidates includes istaroxime, a Phase 2 candidate with sarco endoplasmic reticulum Ca2+ -ATPase 2a, or SERCA2a, activating properties for acute heart failure and associated cardiogenic shock, preclinical SERCA2a activators for heart failure, rostafuroxin for the treatment of hypertension in patients with a specific genetic profile, and a preclinical atypical protein kinase C iota, or aPKCi, inhibitor, being developed for potential application in rare and broad oncology indications. It operates in one operating segment, which is the research and development of products focused on cardiovascular disease.
| Founded: | 1992 | Country: | United States |
| Employees: | N/A | City: | WARRINGTON |
| Market Cap: | 3.6M | IPO Year: | 1995 |
| Target Price: | $350.00 | AVG Volume (30 days): | 260.9K |
| Analyst Decision: | Hold | Number of Analysts: | 1 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -64.36 | EPS Growth: | N/A |
| 52 Week Low/High: | $0.55 - $737.43 | Next Earning Date: | 05-16-2025 |
| Revenue: | N/A | Revenue Growth: | N/A |
| Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
Latest Windtree Therapeutics Inc. News
WINT Breaking Stock News: Dive into WINT Ticker-Specific Updates for Smart Investing
Leasing Life
8 days ago
Ares and Ansley Park Capital provide asset-based and equipment financing to Shimmick
Offshore Technology
8 days ago
BP, EOG achieve first gas from Mento field, offshore Trinidad
AFP
8 days ago
Macron urges Asia, Europe to unite to resist 'spheres of coercion'
Footwear News
8 days ago
Name Game: Shoe Carnival Is Converting More Stores to Shoe Station Banner
Business Wire
8 days ago
Form 8.3 - American Axle & Manufacturing Holdings, Inc.
Investopedia
8 days ago
Ulta Stock Jumps as Beauty Product Spending Continues
GlobeNewswire
8 days ago
Silicon Photonics Market Set to Surge to USD 13.9 Billion by 2034, Driven by 12.5% CAGR | Exactitude Consultancy
PR Newswire
8 days ago
Anti-money Laundering (AML) Market worth $9.38 billion by 2030- Exclusive Report by MarketsandMarkets™
Compare WINT vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "WINT Windtree Therapeutics Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.